Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bswhite
    Junior Member
    • Jan 2014
    • 5

    #1

    gene-level effects in DEXSeq

    Hi,

    I've just updated to DEXSeq 1.10.8. The manual claims that DEXSeq
    fits a GLM for each gene (section 3.4 Testing for differential exon
    usage), which I would expect. However, the formulae presented in that
    section do not include any gene-level effects:

    e.g., full model ~ sample + exon + condition:exon

    In previous versions of DEXSeq incorporating the gene effect would
    have been accomplished by selecting out the (exon) count rows
    corresponding to a gene and performing the test individual on those
    rows. i.e., with testGeneForDEU. But I don't see any similar partitioning
    of the data by gene in DEXSeq 1.10.8. Can someone verify that it
    is indeed fitting the GLM on a per-gene basis and how it is doing so?
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    It'll fit whatever design you give it with a GLM. You typically don't need to explicitly add "condition" since it's a linear sum of "sample", which would normally make the resulting model matrix rank insufficient.

    Comment

    • bswhite
      Junior Member
      • Jan 2014
      • 5

      #3
      Thanks. But I wasn't understanding how the gene level effect was accounted
      for given that I thought each row of the _original_ matrix of exon counts
      was processed independently. That last assumption was incorrect
      and lead to my confusion.

      Previous versions of DEXSeq aggregated rows sharing a gene in testForDEU. In this version that aggregation into "this" and "other" exons happens in DEXSeqDataSet. So that each row of the augmented matrix has the
      original counts for the exon and the summed counts for all other exons.

      This is started pretty clearly in the manual, I just missed it (e.g., section 3.1 Loading and inspecting the sample data). Hence, the gene level effect is
      absorbed into the 'sample' term (as stated in Section 3.4 Testing for differential expression).

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...